Goldman Sachs’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.7M Buy
+74,900
New +$3.8M ﹤0.01% 4157
2024
Q2
– Sell
-51,700
Closed -$3.03M – 5780
2024
Q1
$3.03M Buy
+51,700
New +$2.92M ﹤0.01% 3533

Other funds holding IHI

Goldman Sachs's IHI Position: Q2 2026 in Review

Goldman Sachs reduced its iShares US Medical Devices ETF (IHI) stake by 69% in Q2 2026, selling an estimated $62.4M and leaving 548,004 shares worth $27.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2361.

Goldman Sachs first reported a position in IHI in Q2 2013 and has held it in 53 quarters since. The position peaked at $118M in Q2 2019. 505 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Goldman Sachs held 548,004 shares of iShares US Medical Devices ETF worth $27.1M as of Q2 2026.
  • Goldman Sachs sold 1,229,792 iShares US Medical Devices ETF shares in Q2 2026, an estimated $62.4M.
  • iShares US Medical Devices ETF made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #2361 holding.
  • Goldman Sachs first reported a position in iShares US Medical Devices ETF in Q2 2013 and has held it in 53 quarters since.
  • Goldman Sachs's iShares US Medical Devices ETF position peaked at $118M in Q2 2019.
  • 505 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.